Vertex, Inc. (NASDAQ:VERX) Q3 2024 Earnings Call Transcript November ... We landed a very high-profile new logo deal with a ...

Vertex, Inc. ( (VERX) ) has released its Q3 earnings. Here is a breakdown of the information Vertex, Inc. presented to its investors. Vertex, ...

VertexPharma wants to transform the treatment of pain. An upcoming sciatica clinical trial readout will be pivotal.

Vertex Inc (VERX) reports impressive financial results with significant cloud revenue growth and strategic expansion through ...

KING OF PRUSSIA, PA — Vertex, Inc. (NASDAQ: VERX) has announced robust financial results for the third quarter of 2024, ...

Vertex (VERX – Research Report), the Technology sector company, was revisited by a Wall Street analyst today. Analyst Chris Quintero from ...

Vertex (VERX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of 14 cents per share. The company posted revenue of $170.4 million in the period, which also beat Street ...

As Vertex Pharmaceuticals Inc. heads toward the end of 2024, the Boston drugmaker is gearing up for two potential drug ...

Hello and thanks for joining us to discuss Vertex Inc third quarter financial results. I'm Joe Crivelli, Vice President, Investor Relations, David DiStefano, our President and CEO and John Schwab. Our ...

Q3 2024 Earnings Conference Call November 6, 2024 8:30 AM ETCompany ParticipantsJoe Crivelli - Vice President, ...